BALA CYNWYD, Pa. -- (Business Wire)
Law office of Brodsky & Smith, LLC announces that it is investigating
potential claims against the Board of Directors of Auspex
Pharmaceuticals, Inc. ("Auspex” or "the Company") (Nasdaq: ASPX) for
possible breaches of fiduciary duty and other violations of state law in
connection with the sale of the Company to Teva Pharmaceuticals
Industries Ltd. (“Teva”).
Click here to learn more about the investigation http://brodsky-smith.com/910-aspx-auspex-pharmaceuticals-inc.html,
or call: 877-534-2590. There is no cost or obligation to you.
Under the terms of the transaction, Auspex shareholders will receive
only $101.00 in cash for each share of Auspex stock they own. The
investigation concerns whether the Board of Auspex breached their
fiduciary duties to stockholders by failing to adequately shop the
Company before agreeing to enter into this transaction, and whether Teva
is underpaying for Auspex.
The transaction may undervalue Auspex which next year has its SD-809
drug scheduled for a commercial launch as a treatment for Huntington
disease. However, SD-809 also is a potential treatment for tardive
dyskinesia, which is a frequent side effect of anti-psychotic drugs. In
addition, SD-809 is being studied as a potential treatment for
Tourette’s syndrome. As a result, it has been estimated that SD-809
could have peak annual sales of $2 billion and an analyst has set a
$105.00 per share price target for Auspex stock.
If you own shares of Auspex stock and wish to discuss the legal
ramifications of the investigation, or have any questions, you may
e-mail or call the law office of Brodsky & Smith, LLC who will, without
obligation or cost to you, attempt to answer your questions. You may
contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky &
Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA 19004, by
visiting http://brodsky-smith.com/910-aspx-auspex-pharmaceuticals-inc.html,
or calling toll free 877-LEGAL-90.
Brodsky & Smith, LLC is a litigation law firm with extensive expertise
representing shareholders throughout the nation in securities and class
action lawsuits. The attorneys at Brodsky & Smith have been appointed by
numerous courts throughout the country to serve as lead counsel in class
actions and have successfully recovered millions of dollars for our
clients and shareholders. Attorney advertising. Prior results do not
guarantee a similar outcome.
Contacts:
Brodsky & Smith, LLC
Jason L. Brodsky, Esquire
Evan J.
Smith, Esquire
877-LEGAL-90
http://brodsky-smith.com/910-aspx-auspex-pharmaceuticals-inc.html
Source: Brodsky & Smith, LLC
© 2024 Canjex Publishing Ltd. All rights reserved.